Cite
HARVARD Citation
Nishikawa, N. et al. (n.d.). 14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. International journal of gynecological cancer. pp. A10-A11. [Online].